Marshall Wace’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$945K Sell
103,528
-185,372
-64% -$1.55M ﹤0.01% 2162
2025
Q4
$2.15M Buy
288,900
+1,281
+0.4% +$9.21K ﹤0.01% 1545
2025
Q3
$1.92M Buy
287,619
+75,924
+36% +$527K ﹤0.01% 1642
2025
Q2
$1.4M Buy
211,695
+51,951
+33% +$368K ﹤0.01% 1708
2025
Q1
$1.46M Buy
159,744
+86,321
+118% +$862K ﹤0.01% 1611
2024
Q4
$771K Sell
73,423
-307,404
-81% -$3.64M ﹤0.01% 1853
2024
Q3
$4.55M Buy
380,827
+48,536
+15% +$420K 0.01% 1030
2024
Q2
$1.91M Buy
332,291
+91,843
+38% +$504K ﹤0.01% 1394
2024
Q1
$1.25M Buy
240,448
+49,813
+26% +$243K ﹤0.01% 1559
2023
Q4
$1M Sell
190,635
-74,314
-28% -$294K ﹤0.01% 1478
2023
Q3
$874K Buy
264,949
+194,178
+274% +$681K ﹤0.01% 1543
2023
Q2
$205K Buy
+70,771
New +$136K ﹤0.01% 2239
2022
Q2
Sell
-10,440
Closed -$147K 3467
2022
Q1
$147K Sell
10,440
-164,751
-94% -$2.21M ﹤0.01% 3145
2021
Q4
$2.54M Buy
+175,191
New +$2.49M 0.01% 1886
2021
Q2
Sell
-20,756
Closed -$317K 2684
2021
Q1
$317K Buy
+20,756
New +$296K ﹤0.01% 2110

Other funds holding BVS